It also discusses the experimental evidence for MR’s cross-talk with cardiac G protein-coupled receptors (GPCRs), highlighting novel, cardiac-specific aspects of MR signaling that can be exploited for cardiovascular disease therapy. The gene discussed is NR3C2; the disease is cardiovascular disorder.